Valuation: G MEDPAR

Market Cap 7L 6L 6L 5L 10.01L 6.89Cr 10.11L 68.47L 26.66L 3.48Cr 27.15L 26.56L 12Cr P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 25.2L 21.59L 20.23L 18.48L 34.88L 24Cr 35.22L 2.39Cr 92.91L 12Cr 94.62L 92.56L 40Cr EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.03
3 years 0
Extreme 1.0E-6
0.1
5 years 0
Extreme 1.0E-6
235.9
10 years 0
Extreme 1.0E-6
235.9
Manager TitleAgeSince
Chief Executive Officer 75 03/10/2014
Director of Finance/CFO 46 31/07/2022
Chief Tech/Sci/R&D Officer 56 01/12/2017
Director TitleAgeSince
Director/Board Member 75 03/10/2014
Chairman 72 21/08/2014
Director/Board Member 76 24/02/2017
Date Insider Type Main position Quantity % Market Cap.
31/03/23
AWM Investment Co., Inc.
SellCompany 7,37,500 37.5554%
31/03/23
AWM Investment Co., Inc.
OtherCompany 14,37,500 73.2011%

Financials

2021 2022
Net sales 50.58L 43.34L 40.61L 37.1L 70.01L 48Cr 70.7L 4.79Cr 1.86Cr 24Cr 1.9Cr 1.86Cr 81Cr 44.2L 37.87L 35.49L 32.42L 61.18L 42Cr 61.78L 4.19Cr 1.63Cr 21Cr 1.66Cr 1.62Cr 70Cr
Net income -1.48Cr -1.26Cr -1.18Cr -1.08Cr -2.04Cr -140.69Cr -2.06Cr -14Cr -5.44Cr -71Cr -5.54Cr -5.42Cr -235.07Cr -1.35Cr -1.16Cr -1.09Cr -99.17L -1.87Cr -128.9Cr -1.89Cr -13Cr -4.99Cr -65Cr -5.08Cr -4.97Cr -215.37Cr
Net Debt 24.08L 20.63L 19.33L 17.66L 33.33L 23Cr 33.66L 2.28Cr 88.78L 12Cr 90.42L 88.45L 38Cr 17.97L 15.4L 14.43L 13.18L 24.87L 17Cr 25.12L 1.7Cr 66.26L 8.64Cr 67.47L 66L 29Cr
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
-
Sector
-
Date Price Change Volume
24/26/24 $0.000100 -.--% 1,322
  1. Stock Market
  2. Stocks
  3. GMVDF Stock